Banco Santander, S.A. Alnylam Pharmaceuticals, Inc. Transaction History

Banco Santander, S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$120.42 - $169.29 $4.82 Million - $6.77 Million	-40,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$127.18 - $173.91 $5.09 Million - $6.96 Million	40,000 New	40,000 $6.53 Million
Q3 2020 Nov 09, 2020	SELL	$121.19 - $165.49 $415,560 - $567,465	-3,429 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$104.21 - $156.44 $357,336 - $536,432	3,429 New	3,429 $508,000

614

108M

2.33M

2.17M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Santander, S.A. with notifications on news.